+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Continuous Bioprocessing Market Research Report by Product, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5012940
  • Report
  • July 2020
  • Region: Global
  • 214 pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2020

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Continuous Bioprocessing Market to Grow USD 12,106.36 Million by 2025, at a CAGR of 10.37%

FEATURED COMPANIES

  • 3M Company
  • Danaher Corporation
  • Eppendorf AG
  • GE Healthcare
  • Merck KGaA
  • Repligen Corporation
  • MORE
The Global Continuous Bioprocessing Market is expected to grow from USD 6,695.49 Million in 2019 to USD 12,106.36 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 10.37%.

Market Segmentation & Coverage:

This research report categorizes the Continuous Bioprocessing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Continuous Bioprocessing Market studied across Bioreactors, Centrifuges, Chromatography System & Consumable, Filtration Systems and Consumables, Incubators & Shakers, Mixing Systems, and Cell Culture Media & Reagent.

Based on End-User, the Continuous Bioprocessing Market studied across Academic and Research Institutes, Contract Development and Manufacturing Organizations (CDMOs), and Pharmaceutical & Biotechnology Companies.

Based on Geography, the Continuous Bioprocessing Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Continuous Bioprocessing Market including 3M Company, Applikon Biotechnology B.V., Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf AG, GE Healthcare, Merck KGaA, Repligen Corporation, Sartorius AG, and Thermo Fisher Scientific Inc..

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Continuous Bioprocessing Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Continuous Bioprocessing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Continuous Bioprocessing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Continuous Bioprocessing Market?
4. What is the competitive strategic window for opportunities in the Global Continuous Bioprocessing Market?
5. What are the technology trends and regulatory frameworks in the Global Continuous Bioprocessing Market?
6. What are the modes and strategic moves considered suitable for entering the Global Continuous Bioprocessing Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Danaher Corporation
  • Eppendorf AG
  • GE Healthcare
  • Merck KGaA
  • Repligen Corporation
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Market Outlook
3.2. Product Outlook
3.3. End-User Outlook
3.4. Geography Outlook
3.5. Competitor Outlook

4. Market Overview
4.1. Introduction

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Growing demand for biopharmaceuticals & government support for the industry
5.2.2. Increased benefits over batch processing & uptake of single use technology
5.2.3. Advent of Industry 4.0 & trend towards automation & digitization
5.3. Restraints
5.3.1. Difficulties in adoption of continuous downstream purification operations due to with fewer technology options
5.3.2. Perception issues with continuous bioprocessing
5.4. Opportunities
5.4.1. Adoption of perfusion associated with single-use equipment
5.4.2. Development of a continuous bioprocessing approach to stromal cell manufacturing
5.5. Challenges
5.5.1. High risk of contamination with continuous bioprocessing
5.5.2. Dearth of bioprocessing professionals

6. Market Insights
6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations
6.3.1. Automation & Robotic Process Integration

7. Global Continuous Bioprocessing Market, By Product
7.1. Introduction
7.2. Bioreactors
7.3. Centrifuges
7.4. Chromatography System & Consumable
7.5. Filtration Systems and Consumables
7.6. Incubators & Shakers
7.7. Mixing Systems
7.8. Cell Culture Media & Reagent

8. Global Continuous Bioprocessing Market, By End-User
8.1. Introduction
8.2. Academic and Research Institutes
8.3. Contract Development and Manufacturing Organizations (CDMOs)
8.4. Pharmaceutical & Biotechnology Companies

9. Global Continuous Bioprocessing Market, By Geography
9.1. Introduction
9.2. Americas
9.2.1. Argentina
9.2.2. Brazil
9.2.3. Canada
9.2.4. Mexico
9.2.5. United States
9.3. Asia-Pacific
9.3.1. Australia
9.3.2. China
9.3.3. India
9.3.4. Indonesia
9.3.5. Japan
9.3.6. Malaysia
9.3.7. Philippines
9.3.8. South Korea
9.3.9. Thailand
9.4. Europe, Middle East & Africa
9.4.1. France
9.4.2. Germany
9.4.3. Italy
9.4.4. Netherlands
9.4.5. Qatar
9.4.6. Russia
9.4.7. Saudi Arabia
9.4.8. South Africa
9.4.9. Spain
9.4.10. United Arab Emirates
9.4.11. United Kingdom

10. Competitive Strategic Window
10.1. Introduction
10.2. Competitive Strategic Window, by Product
10.3. Competitive Strategic Window, by End-User
10.4. Competitive Strategic Window, by Geography

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. 3M Company
12.2. Applikon Biotechnology B.V.
12.3. Bio-Rad Laboratories, Inc.
12.4. Danaher Corporation
12.5. Eppendorf AG
12.6. GE Healthcare
12.7. Merck KGaA
12.8. Repligen Corporation
12.9. Sartorius AG
12.10. Thermo Fisher Scientific Inc.

13. Appendix
13.1. Discussion Guide
13.2. Edition Details
13.3. License Details
13.4. Pricing Details

LIST OF FIGURES
FIGURE 1. GLOBAL CONTINUOUS BIOPROCESSING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CONTINUOUS BIOPROCESSING MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
FIGURE 5. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2019 VS 2025 (USD MILLION)
FIGURE 6. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 7. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY TYPE
FIGURE 8. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE GROWTH , 2017-2025 (USD MILLION)
FIGURE 10. GLOBAL CONTINUOUS BIOPROCESSING MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL CONTINUOUS BIOPROCESSING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
FIGURE 13. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2019 VS 2025 (USD MILLION)
FIGURE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 15. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2025
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2025
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 21. GLOBAL CONTINUOUS BIOPROCESSING MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 22. GLOBAL CONTINUOUS BIOPROCESSING MARKET: 360IRESEARCH MARKET SHARE ANALYSIS

LIST OF TABLES
TABLE 1. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 3. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM & CONSUMABLE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 6. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS AND CONSUMABLES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 7. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MIXING SYSTEMS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS), BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 15. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 16. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 17. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 18. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 19. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 20. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 21. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 22. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 23. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 24. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 25. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 26. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 27. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 28. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 29. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 30. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 31. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 32. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 33. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 34. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 35. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 36. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 37. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 38. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 39. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 40. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 41. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 42. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 43. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 44. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 45. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 46. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 47. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 48. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 52. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 53. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 54. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 55. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 56. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 57. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 58. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 59. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 60. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 61. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 62. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 63. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 64. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 65. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 66. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 67. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 68. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 69. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 70. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 71. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 72. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
TABLE 73. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 74. GLOBAL CONTINUOUS BIOPROCESSING MARKET: SCORES
TABLE 75. GLOBAL CONTINUOUS BIOPROCESSING MARKET: BUSINESS STRATEGY
TABLE 76. GLOBAL CONTINUOUS BIOPROCESSING MARKET: PRODUCT SATISFACTION
TABLE 77. GLOBAL CONTINUOUS BIOPROCESSING MARKET: RANKING
TABLE 78. GLOBAL CONTINUOUS BIOPROCESSING MARKET: MERGER & ACQUISITION
TABLE 79. GLOBAL CONTINUOUS BIOPROCESSING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 80. GLOBAL CONTINUOUS BIOPROCESSING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 81. GLOBAL CONTINUOUS BIOPROCESSING MARKET: INVESTMENT & FUNDING
TABLE 82. GLOBAL CONTINUOUS BIOPROCESSING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 83. GLOBAL CONTINUOUS BIOPROCESSING MARKET: EDITION DETAILS
TABLE 84. GLOBAL CONTINUOUS BIOPROCESSING MARKET: LICENSE DETAILS
TABLE 85. GLOBAL CONTINUOUS BIOPROCESSING MARKET: PRICING DETAILS
Note: Product cover images may vary from those shown
  • 3M Company
  • Applikon Biotechnology B.V.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eppendorf AG
  • GE Healthcare
  • Merck KGaA
  • Repligen Corporation
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
Adroll
adroll